These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19633645)

  • 1. Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.
    Weigelt B; Geyer FC; Horlings HM; Kreike B; Halfwerk H; Reis-Filho JS
    Mod Pathol; 2009 Nov; 22(11):1401-14. PubMed ID: 19633645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
    Lacroix-Triki M; Suarez PH; MacKay A; Lambros MB; Natrajan R; Savage K; Geyer FC; Weigelt B; Ashworth A; Reis-Filho JS
    J Pathol; 2010 Nov; 222(3):282-98. PubMed ID: 20815046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.
    Weigelt B; Geyer FC; Natrajan R; Lopez-Garcia MA; Ahmad AS; Savage K; Kreike B; Reis-Filho JS
    J Pathol; 2010 Jan; 220(1):45-57. PubMed ID: 19877120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refinement of breast cancer classification by molecular characterization of histological special types.
    Weigelt B; Horlings HM; Kreike B; Hayes MM; Hauptmann M; Wessels LF; de Jong D; Van de Vijver MJ; Van't Veer LJ; Peterse JL
    J Pathol; 2008 Oct; 216(2):141-50. PubMed ID: 18720457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas.
    Lopez-Garcia MA; Geyer FC; Natrajan R; Kreike B; Mackay A; Grigoriadis A; Reis-Filho JS; Weigelt B
    J Pathol; 2010 Sep; 222(1):64-75. PubMed ID: 20593406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
    Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
    Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of microsatellite instability in mucinous carcinomas of the breast.
    Lacroix-Triki M; Lambros MB; Geyer FC; Suarez PH; Reis-Filho JS; Weigelt B
    Int J Clin Exp Pathol; 2010 Nov; 4(1):22-31. PubMed ID: 21228925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinoma.
    Pareja F; Selenica P; Brown DN; Sebastiao APM; da Silva EM; Da Cruz Paula A; Del A; Fu L; Weigelt B; Brogi E; Reis-Filho JS; Wen HY
    Histopathology; 2019 Jul; 75(1):139-145. PubMed ID: 30843622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.
    Righi L; Sapino A; Marchiò C; Papotti M; Bussolati G
    Semin Diagn Pathol; 2010 Feb; 27(1):69-76. PubMed ID: 20306832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine carcinomas of the breast.
    Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
    Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters.
    Tse GM; Ma TK; Chu WC; Lam WW; Poon CS; Chan WC
    Mod Pathol; 2004 May; 17(5):568-72. PubMed ID: 15001999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
    Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
    J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A morphological and immunohistochemical study of ductal carcinoma in situ, invasive breast carcinoma of no special type, and mucinous carcinoma of the breast in comparison with solid papillary carcinoma regarding neuroendocrine marker expression.
    Otsuki Y; Asano Y; Ikeya T; Ishida Y; Sezaki S; Kobayashi H
    Virchows Arch; 2024 Sep; 485(3):547-555. PubMed ID: 38958708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine differentiation in carcinoma of the breast. Tyramide signal amplification discloses chromogranin A-positive tumour cells in more breast tumours than previously realized.
    Bofin AM; Qvigstad G; Waldum C; Waldum HL
    APMIS; 2002 Sep; 110(9):658-64. PubMed ID: 12529020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucin expression in mucinous carcinoma and other invasive carcinomas of the breast.
    Chu JS; Chang KJ
    Cancer Lett; 1999 Jul; 142(1):121-7. PubMed ID: 10424790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
    Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
    Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroendocrine expression markers in triple-negative, luminal-A, luminal-B and HER2neu breast cancer].
    Barboza-García YG; Ramírez-Balderrama L; Murguía-Pérez M; Hernández-González MA; Landeros-Navarro IY
    Rev Med Inst Mex Seguro Soc; 2024 Jan; 62(1):1-7. PubMed ID: 39110839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
    Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
    Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic profiling of histological special types of breast cancer.
    Horlings HM; Weigelt B; Anderson EM; Lambros MB; Mackay A; Natrajan R; Ng CK; Geyer FC; van de Vijver MJ; Reis-Filho JS
    Breast Cancer Res Treat; 2013 Nov; 142(2):257-69. PubMed ID: 24162157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.